Picture of Standard BioTools logo

LAB — Standard BioTools News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Fluidigm Corp reports results for the quarter ended in December - Earnings Summary

* Fluidigm Corp  FLDM.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for a loss of 28 cents per
share.
    * Revenue fell 14.2% to $38.27 million from a year ago; 
analysts
expected $32.70 million. 
    * Fluidigm Corp's reported EPS for the quarter was a loss
of 12
cents​.
    * The mean earnings estimate of analysts had fallen by
about 75%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Fluidigm Corp shares had fallen by 10.5% this quarter.
    * The company reported a quarterly loss of $9.43 million.
    * Wall Street's median 12-month price target for Fluidigm
Corp is
$10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated February 17 at 11:32 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Standard BioTools

See all news